Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06138054 · ClinicalTrials.gov registry record · NA

MI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMI

A NA study of Homelessness and Schizophrenia Spectrum Disorders, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06138054: Recruiting NA study of Homelessness and Schizophrenia Spectrum Disorders, sponsored by VA Office of Research and Development.

NCT06138054 is a NA study of Homelessness and Schizophrenia Spectrum Disorders that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 50 participants, below the 446-participant average among 8 other Homelessness trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06138054, a NA study of Homelessness and Schizophrenia Spectrum Disorders, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study aims to test the feasibility and acceptability of a brief behavioral intervention that combines two treatments, Motivational Interviewing (MI) and Cognitive Behavioral Therapy (CBT), that have been shown to work in prior research studies. The format of the intervention will be a combination of in-person sessions and remote elements delivered via mobile phone (together called MI-CBTech). The goal of the intervention is to improve community integration in Veterans with serious mental illness (SMI) who have experienced homelessness. A time- and format-matched control arm will include remote mindfulness training. 50 Veterans with SMI experiencing homelessness will be randomized to one of the two arms (25 per arm).

Primary Outcome

The investigators will assess feasibility of both MI-CBTech and mindfulness control treatment arms based on recruitment using a completion rate of at least 80% for the baseline in-person assessment.

Interventions

  • BEHAVIORAL MI-CBTech
  • BEHAVIORAL Mindfulness control

Study Locations (1)

California

  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-04-01
Est. Completion 2026-12-31
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT06138054 shows while recruiting

NCT06138054 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 446-participant average among 8 other Homelessness trials with a reported enrollment target (89% lower).

The record links to 5 conditions, with Homelessness appearing as the primary indexed condition, and to 2 interventions - of which MI-CBTech is the first listed.

NCT06138054 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06138054 about?

NCT06138054 is a clinical study titled "MI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMI". This study aims to test the feasibility and acceptability of a brief behavioral intervention that combines two treatments, Motivational Interviewing (MI) and Cognitive Behavioral Therapy (CBT), that have been shown to work in prior research studies. The format of the intervention will be a combinati...

What is the current status of trial NCT06138054?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-04-01. Estimated completion is 2026-12-31.

What conditions does trial NCT06138054 study?

This clinical trial studies the following conditions: Homelessness, Schizophrenia Spectrum Disorders, Psychotic Affective Disorders, Psychotic Mood Disorders, Ill-Housed Persons.

What interventions are being tested in trial NCT06138054?

The interventions under investigation include: MI-CBTech (BEHAVIORAL), Mindfulness control (BEHAVIORAL).

Who is sponsoring clinical trial NCT06138054?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06138054 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Homelessness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06138054's enrollment target sits among peer trials

50 9th of 8 the lowest of 8 other Homelessness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Homelessness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06138054, the US trial registry maintained by the National Library of Medicine. NCT06138054 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.